Stonegate Capital Partners Updates Coverage On GoHealth Inc. (GOCO) 2025 Q2
GoHealth Inc. (NASDAQ: GOCO) reported challenging Q2 2025 results, with net revenues declining 11.2% year-over-year to $94.0M. The company experienced significant decreases in partner revenue (-44.4%) and non-agency revenue (-79.4%), partially offset by growth in GoHealth Protect segment.
The company secured $115M in new and rolled-up loans and amended its credit agreement to waive near-term principal payments. Q2 resulted in a $115.9M net loss, including a $53M intangible asset impairment charge, though adjusted EBITDA showed slight improvement to -$11.3M year-over-year. Cost efficiency improved with marketing and consumer care expenses declining 26% and 33% respectively.
GoHealth Inc. (NASDAQ: GOCO) ha riportato risultati difficili nel secondo trimestre del 2025, con ricavi netti in calo dell'11,2% su base annua a 94,0 milioni di dollari. L'azienda ha registrato significative diminuzioni nei ricavi da partner (-44,4%) e nei ricavi non da agenzia (-79,4%), parzialmente compensate dalla crescita del segmento GoHealth Protect.
La societ脿 ha ottenuto 115 milioni di dollari in nuovi prestiti e rifinanziamenti e ha modificato il proprio accordo di credito per sospendere i pagamenti principali a breve termine. Il secondo trimestre si 猫 chiuso con una perdita netta di 115,9 milioni di dollari, inclusa una svalutazione di attivit脿 immateriali di 53 milioni di dollari, anche se l'EBITDA rettificato ha mostrato un leggero miglioramento, attestandosi a -11,3 milioni di dollari su base annua. L'efficienza dei costi 猫 migliorata con una riduzione delle spese di marketing e assistenza ai consumatori rispettivamente del 26% e 33%.
GoHealth Inc. (NASDAQ: GOCO) report贸 resultados desafiantes en el segundo trimestre de 2025, con ingresos netos que disminuyeron un 11,2% interanual hasta 94,0 millones de d贸lares. La compa帽铆a experiment贸 ca铆das significativas en los ingresos de socios (-44,4%) y en los ingresos no relacionados con agencias (-79,4%), parcialmente compensadas por el crecimiento en el segmento GoHealth Protect.
La empresa asegur贸 115 millones de d贸lares en nuevos pr茅stamos y refinanciamientos y modific贸 su acuerdo de cr茅dito para eximir los pagos principales a corto plazo. El segundo trimestre termin贸 con una p茅rdida neta de 115,9 millones de d贸lares, incluyendo un cargo por deterioro de activos intangibles de 53 millones, aunque el EBITDA ajustado mostr贸 una ligera mejora hasta -11,3 millones a帽o tras a帽o. La eficiencia en costos mejor贸 con una reducci贸n del 26% en gastos de marketing y del 33% en atenci贸n al consumidor.
GoHealth Inc. (NASDAQ: GOCO)電� 2025雲� 2攵勱赴鞐� 鞏措牑鞖� 鞁れ爜鞚� 氤搓碃頄堨溂氅�, 靾滊Г於滌潃 鞝勲厔 雽�牍� 11.2% 臧愳唽頃� 9,400毵� 雼煬毳� 旮半頄堨姷雼堧嫟. 须岇偓电� 韺岉姼雱� 毵れ稖鞚� 44.4% 臧愳唽頃橁碃 牍勲寑頄� 毵れ稖鞚� 79.4% 臧愳唽頃橂姅 霌� 韥� 韽潣 頃橂澖鞚� 瓴棃鞙茧倶, GoHealth Protect 攵�氍胳潣 靹膘灔鞚� 鞚茧秬 靸侅噭頄堨姷雼堧嫟.
须岇偓电� 1鞏� 1,500毵� 雼煬鞚� 鞁犼窚 氚� 鞛湹鞛� 雽�於�鞚� 頇曤炒頃橁碃 雼赴 鞗愱笀 靸來櫂鞚� 氅挫牅頃橂姅 鞁犾毄 瓿勳暯鞚� 臧滌爼頄堨姷雼堧嫟. 2攵勱赴 靾滌啇鞁れ潃 1鞏� 1,590毵� 雼煬鞓�鞙茧┌, 鞚� 欷� 5,300毵� 雼煬鞚� 氍错槙鞛愳偘 靻愳儊彀啇鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟. 雼る 臁办爼 EBITDA電� 鞝勲厔 雽�牍� 靻岉彮 臧滌劆霅橃柎 -1,130毵� 雼煬毳� 旮半頄堨姷雼堧嫟. 毵堨紑韺� 氚� 靻岆箘鞛� 甏�毽� 牍勳毄鞚� 臧侁皝 26%, 33% 臧愳唽頃橃棳 牍勳毄 須湪靹膘澊 頄レ儊霅橃棃鞀惦媹雼�.
GoHealth Inc. (NASDAQ : GOCO) a annonc茅 des r茅sultats difficiles pour le deuxi猫me trimestre 2025, avec des revenus nets en baisse de 11,2 % en glissement annuel 脿 94,0 millions de dollars. L'entreprise a subi des baisses importantes des revenus partenaires (-44,4 %) et des revenus hors agence (-79,4 %), partiellement compens茅es par la croissance du segment GoHealth Protect.
La soci茅t茅 a obtenu 115 millions de dollars de nouveaux pr锚ts et de pr锚ts regroup茅s et a modifi茅 son accord de cr茅dit pour suspendre les paiements de principal 脿 court terme. Le deuxi猫me trimestre s'est sold茅 par une perte nette de 115,9 millions de dollars, incluant une charge de d茅pr茅ciation d'actifs incorporels de 53 millions, bien que l'EBITDA ajust茅 ait montr茅 une l茅g猫re am茅lioration 脿 -11,3 millions en glissement annuel. L'efficacit茅 des co没ts s'est am茅lior茅e avec une baisse des d茅penses marketing et service client respectivement de 26 % et 33 %.
GoHealth Inc. (NASDAQ: GOCO) meldete herausfordernde Ergebnisse f眉r das zweite Quartal 2025, mit einem R眉ckgang der Nettoums盲tze um 11,2% im Jahresvergleich auf 94,0 Mio. USD. Das Unternehmen verzeichnete erhebliche R眉ckg盲nge bei den Partnererl枚sen (-44,4%) und den Nicht-Agentur-Erl枚sen (-79,4%), die teilweise durch Wachstum im GoHealth Protect-Segment ausgeglichen wurden.
Das Unternehmen sicherte sich 115 Mio. USD an neuen und zusammengefassten Krediten und 盲nderte seine Kreditvereinbarung, um kurzfristige Tilgungszahlungen auszusetzen. Das zweite Quartal endete mit einem Nettoverlust von 115,9 Mio. USD, einschlie脽lich einer Wertminderung von immateriellen Verm枚genswerten in H枚he von 53 Mio. USD, wobei das bereinigte EBITDA eine leichte Verbesserung auf -11,3 Mio. USD im Jahresvergleich zeigte. Die Kosteneffizienz verbesserte sich durch R眉ckg盲nge der Marketing- und Verbraucherkosten um 26 % bzw. 33 %.
- None.
- Net revenues declined 11.2% year-over-year to $94.0M
- Partner revenue dropped 44.4% and non-agency revenue fell 79.4%
- Reported substantial net loss of $115.9M in Q2
- $53M intangible asset impairment charge
- Total submissions declined 7.5%
Dallas, Texas--(Newsfile Corp. - August 8, 2025) - GoHealth Inc. (NASDAQ: GOCO): Stonegate Capital Partners updates their coverage on GoHealth Inc. (NASDAQ: GOCO). GoHealth, Inc. delivered a challenged second quarter in 2025, highlighted by revenue declines and contracting margins. Net revenues decreased
To view the full announcement, including downloadable images, bios, and more, .
Key Takeaways:
- Secured
$115M in new and rolled-up loans, amended credit agreement waiving near-term principal payments, and created$250M debt basket to pursue strategic deals. - Reported a
$115.9M net loss in Q2, impacted by a$53M intangible asset impairment charge; adjusted EBITDA improved slightly y/y to -$11.3M . - Marketing and consumer care expenses fell
26% and33% y/y, respectively, driving improved cost efficiency per submission despite a7.5% decline in total submissions.
Click image above to view full announcement.
About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.
Contacts:
Stonegate Capital Partners
(214) 987-4121
[email protected]
Source:
To view the source version of this press release, please visit
FAQ
What were GoHealth's (GOCO) Q2 2025 financial results?
How much did GOCO's partner and non-agency revenues decline in Q2 2025?
What cost reduction measures did GoHealth (GOCO) implement in Q2 2025?
What new financing did GoHealth (GOCO) secure in Q2 2025?
How did GOCO's submission volumes perform in Q2 2025?
